Cargando…

Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation

BACKGROUND: An individual prognostic model that includes inflammation caused by the delayed recovery of liver function after surgery for the early recurrence of hepatocellular carcinoma (HCC) following liver transplantation (LT) has not been well determined. Our aim was to develop a nomogram model f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ensi, Li, Jianhua, Xing, Hao, Li, Ruidong, Shen, Conghuan, Zhang, Quanbao, Ma, Zhenyu, Tao, Yifeng, Qin, Lunxiu, Zhao, Jing, Wang, Zhengxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039665/ https://www.ncbi.nlm.nih.gov/pubmed/33850865 http://dx.doi.org/10.21037/atm-21-334

Ejemplares similares

Itaconic acid facilitates inflammation abatement and alleviates liver ischemia-reperfusion injury by inhibiting NF-κB/NLRP3/caspase-1 inflammasome axis
por: Ma, Ensi, et al.
Publicado: (2022)

Effects of Tumor-Derived DNA on CXCL12-CXCR4 and CCL21-CCR7 Axes of Hepatocellular Carcinoma Cells and the Regulation of Sinomenine Hydrochloride
por: Shen, Conghuan, et al.
Publicado: (2022)

SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T
por: Tao, Yifeng, et al.
Publicado: (2020)

Cancer Cell-Derived Exosomes Promote HCC Tumorigenesis Through Hedgehog Pathway
por: Li, Li, et al.
Publicado: (2021)

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis
por: Sun, Chao, et al.
Publicado: (2023)

Comparison of Two Donor Liver Procurement Methods for Treatment of Pediatric Acute Liver Failure
por: Pei, Jiahao, et al.
Publicado: (2022)

Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: A two-center experience
por: Dong, Jian, et al.
Publicado: (2016)

Omicron infections profile and vaccination status among 1881 liver transplant recipients: a multi-centre retrospective cohort
por: Ma, Ensi, et al.
Publicado: (2022)

Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver Transplantation
por: Feng, Jiliang, et al.
Publicado: (2019)

Nomogram predicting pulmonary metastasis of hepatocellular carcinoma after liver transplantation
por: Huang, Li-Feng, et al.
Publicado: (2017)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
por: Jin, Xin, et al.
Publicado: (2022)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation
por: Feng, Jiliang, et al.
Publicado: (2017)

Independent prognostic factors for posttransplant survival in hepatocellular carcinoma patients undergoing liver transplantation
por: Xing, Minzhi, et al.
Publicado: (2016)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma
por: Wei, Jinwang, et al.
Publicado: (2019)

Impact of Hypothyroidism on Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
por: Salman, Ahmed, et al.
Publicado: (2021)

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series
por: Simsek, Cem, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments
por: Sun, Yu, et al.
Publicado: (2023)

Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant
por: Guo, Yuxin, et al.
Publicado: (2019)

Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction
por: Zhang, Zhen, et al.
Publicado: (2019)

A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study
por: Zhang, Li, et al.
Publicado: (2019)

CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
por: Jia, Qingan, et al.
Publicado: (2015)

Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence
por: Rahimi, Robert S., et al.
Publicado: (2015)

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
por: Kim, Jong Man
Publicado: (2021)

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)

Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation
por: Xue, Feng, et al.
Publicado: (2018)

Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019)

Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
por: Ma, Ka Wing, et al.
Publicado: (2019)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
por: Pan, Yang-Xun, et al.
Publicado: (2019)

Apatinib is effective for treatment of advanced hepatocellular carcinoma
por: Kong, Yinlong, et al.
Publicado: (2017)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
por: Liu, Fei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j88rkhui1mm9613o5v7sa35o4u